Drugs / TRIV-509
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07167758 | Aug 2025 → Oct 2026 expected | atopic eczema | Triveni Bio | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRIV-509 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07167758 ↗ |
| Route | Subcutaneous | “TRIV-509 (Subcutaneous injection)” NCT07167758 ↗ |